Search Orphan Drug Designations and Approvals
-
| Generic Name: | bryostatin-1 |
|---|---|
| Date Designated: | 12/03/2001 |
| Orphan Designation: | For use in combination with paclitaxel in the treatment of esophageal cancer |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
GPC Biotech, Inc. 610 Lincoln Street Waltham, Massachusetts 02451 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
-
